Latest Advice
The most common symptoms of coronavirus (COVID-19) are recent onset of:
  • New continuous cough and/or
  • High temperature
  • loss or change to your sense of smell or taste  

For most people, coronavirus (COVID-19) will be a mild illness If you have coronavirus symptoms:
  • Do not go to a GP surgery, pharmacy or hospital
  • You do not need to contact 111 to tell them you're staying at home
  • Testing for coronavirus is not needed if you're staying at home
  • Plan ahead and ask others for help to ensure that you can successfully stay at home and consider what can be done for vulnerable people in the household
  • Ask your employer, friends and family to help you to get the things you need to stay at home
  • Wash your hands regularly for 20 seconds, each time using soap and water, or use hand sanitiser
  • If you feel you cannot cope with your symptoms at home, or your condition gets worse, or your symptoms do not get better after 7 days, then use the NHS 111 online coronavirus service. If you do not have internet access, call NHS 111. For a medical emergency dial 999
  • Visit NHS 111 Online for more information

Stay at Home
  • If you live alone and you have symptoms of coronavirus illness (COVID-19), however mild, stay at home for 7 days from when your symptoms started. (See ending isolation section below for more information)
  • If you live with others and you or one of them have symptoms of coronavirus, then all household members must stay at home and not leave the house for 14 days. The 14-day period starts from the day when the first person in the house became ill
  • It is likely that people living within a household will infect each other or be infected already. Staying at home for 14 days will greatly reduce the overall amount of infection the household could pass on to others in the community
  • For anyone in the household who starts displaying symptoms, they need to stay at home for 7 days from when the symptoms appeared, regardless of what day they are on in the original 14 day isolation period. (See ending isolation section below for more information
  • If you can, move any vulnerable individuals (such as the elderly and those with underlying health conditions) out of your home, to stay with friends or family for the duration of the home isolation period
  • If you cannot move vulnerable people out of your home, stay away from them as much as possible
Find out more about UK Gov Coronavirus Response
Don't show this again
Shopping Cart
In Store
Total Excl VAT
Open Hours
What we have to say about your health and well being
Oct 2013
Children dying over vaccine delay
‘Children dying’ over vaccine delay Dubbed “the silent killer”, meningitis is feared by parents because it mostly affects young children, develops rapidly and the symptoms are easily confused with less serious infections such as flu. Children are dying unnecessarily because of official delays in evaluating the suitability of a new vaccine for meningitis B, drug giant Novartis has claimed. The company, which received EU approval for its Bexsero vaccine last December, has criticised the time taken by Irish authorities to evaluate its suitability for inclusion in the national immunisation programme. It says it submitted information about Bexsero to the National Immunisation Advisory Committee last year, prior to its approval by EU authorities. Senior medical development adviser Judith Abernethy said it hadn’t heard anything since and couldn’t talk to the Department of Health about cost issues until the committee makes a decision. “We’re prepared to make this work and we’re open to discussions with Government over cost but we need to be able to speak to them first,” she said. A spokeswoman for the committee said the matter was “under consideration” and would be dealt with at a forthcoming meeting. The next meeting is scheduled for late November. Vaccines are introduced into the childhood immunisation schedule based on the recommendation of the committee and subject to approval by the department after consideration of the cost implications. Highest rates Ireland has one of the highest rates of meningitis infection in Europe, with more than three times the average rate of the disease. Dubbed “the silent killer”, meningitis is feared by parents because it mostly affects young children, develops rapidly and the symptoms are easily confused with less serious infections such as flu. One in 10 of those who contract meningitis dies and up to one in five survivors suffer life-long complications such as limb loss, deafness and brain damage. Meningitis B, for which no vaccine was available until Bexsero was developed, accounts for more than 80 per cent of cases of meningococcal disease in Ireland. Cost-effectiveness In the UK, the Joint Committee for Vaccinations and Immunisations recommended against its inclusion in the immunisation schedule on cost-effectiveness grounds. Concerns were also raised about the vaccine’s coverage and its impact on the carriage and transmission of men B bacteria, the Irish Medical Journal noted. However, last Friday, the committee announced it was reviewing the earlier decision after receiving new evidence about the vaccine. Novartis said it remained convinced that strong evidence supported the use of Bexsero. “We hope public health officials come to a swift resolution, because for every month the vaccine is not available, children keep on dying unnecessarily,” said Andrin Oswald, division head, Novartis Vaccines. There were 84 cases of meningitis B infection in Ireland in 2011 and two deaths, according to the Health Protection Surveillance Centre.
5 Monaghan Street, Co Down
County Armagh
BT35 6BB
0044 (0) 28 3026 2110
Contact Us
Premises GPhC Number:
Cookie Policy
Privacy Policy
Terms And Conditions
Copyright 2019